NEUROENDOCRINE CARCINOMA

Clinical trials for NEUROENDOCRINE CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new NEUROENDOCRINE CARCINOMA trials appear

Sign up with your email to follow new studies for NEUROENDOCRINE CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 9 Not yet recruiting 1 Not yet finished but already full! 9 Completed 2

New radiation drug targets tough-to-treat lung and prostate cancers

Disease control Not yet recruiting

This early-stage study tests a new drug (177Lu-DTPA-SC16.56) that delivers radiation directly to cancer cells in people with small-cell lung cancer or neuroendocrine prostate cancer that has worsened after standard chemotherapy. The main goal is to find the safest dose and see if…

Matched conditions: NEUROENDOCRINE CARCINOMA

Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control

Last updated May 17, 2026 03:14 UTC

NEUROENDOCRINE CARCINOMA

Get alerted when new NEUROENDOCRINE CARCINOMA trials appear

New radiation drug targets tough-to-treat lung and prostate cancers